Skip to main content
SpringerLink
Log in

Potential role of Neuregulin 1 and TNF-alpha (−308) polymorphism in schizophrenia patients visiting hospitals in Lahore, Pakistan

  • Published:
Molecular Biology Reports Aims and scope Submit manuscript

Abstract

Schizophrenia is a chronic and disabling disease of the brain. Schizophrenic patients have auditory hallucinations, delusions and reduced social skills. Recent studies suggest that the genetic polymorphisms are linked with development of schizophrenia. Polymorphisms of schizophrenia susceptibility and different cytokine genes act as the genetic markers. The objective of our study is to examine the association between the neuregulin 1 and tumor necrosis factor-α (−308) gene polymorphism with schizophrenia. This association was performed on the basis of molecular biology to screen the mutations of neuregulin 1 and tumor necrosis factor-α (−308) gene in schizophrenic patients by polymorphism analysis. Statistical analysis of the observed data shows that there was an association (P = 0.003) between patient’s group and controls in terms of genotypes of single-nucleotide polymorphism 1 rather than single-nucleotide polymorphism 2 of neuregulin 1. So, heterozygous (adenine/guanine) allelic pattern can be a higher risk factor of schizophrenic patients. Polymorphism of tumor necrosis factor-α (−308) gene indicated frequent presence of homozygous (adenine/adenine) allelic pattern in patient’s group than in controls (P = 0.015). Statistical analysis indicates that the age distribution has significant difference between patient’s group and controls (P = 0.022) while the gender ratio is not significantly different (P = 0.366) between the two groups. It was concluded that in Pakistani population the neuregulin 1 and tumor necrosis factor-α (−308) genes are strongly associated with schizophrenia.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

References

  1. Freedman R (2003) Review article schizophrenia. N Engl J Med 349:1738–1749

    Article  PubMed  CAS  Google Scholar 

  2. Andreasen NC (1995) Symptoms, signs and diagnosis of schizophrenia. Lancet 346:477–481

    Article  PubMed  CAS  Google Scholar 

  3. Muller N, Micheal R, Manfred A, Markus JS (1999) The role of immune function in schizophrenia: an overview. Eur Arch Psychiatry Clin Neurosci 249:IV/62–IV/68

    Google Scholar 

  4. Kronfol Z, Remick DG (2000) Cytokines and the brain: implications for clinical psychiatry. Am J Psychiatry 157:683–694

    Article  PubMed  CAS  Google Scholar 

  5. Raison CL, Miller AH (2004) Brain-immune system interaction: relevance to the pathophysiology and treatment of neuropsychiatric disorders. In: Schatz-berg AF, Nemeroff CB (eds) The American psychiatric publishing textbook of psychopharmacology, 3rd edn. American Psychiatric Press, Washington DC, pp 147–162

    Google Scholar 

  6. Tan EC, Siow-Ann C, Chay-Hoon T, Yik-Ying T, Kaitian P, Rathi M (2003) Tumor necrosis factor-α gene promoter polymorphisms in chronic schizophrenia. Biol Psychiatry 54:1205–1211

    Article  PubMed  CAS  Google Scholar 

  7. Kowalski J, Blada P, Kucia K, Madej A, Herman ZS (2001) Neuroleptics normalize increased release of interleukin-1β and tumor necrosis factor-α from monocytes in schizophrenia. Schizophr Res 50:169–175

    Article  PubMed  CAS  Google Scholar 

  8. Maier W, Schwab S, Rietschel M (2000) The genetics of schizophrenia. Curr Opin Psychiatry 13:3–9

    Article  Google Scholar 

  9. Peltonen L (1995) Schizophrenia: all out for chromosome six. Nature 378:665–666

    Article  PubMed  CAS  Google Scholar 

  10. Wilson AG, Symons JA, McDowell TL, McDevitt HO, Duff GW (1997) Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation. Proc Natl Acad Sci 94:3195–3199

    Article  PubMed  CAS  Google Scholar 

  11. Law AJ, Shannon WC, Hyde TM, Kleinman JE, Harrison PJ (2004) Neuregulin-1 (NRG-1) mRNA and protein in the adult human brain. Neuroscience 127:125–136

    Article  PubMed  CAS  Google Scholar 

  12. Hall D, Gogos JA, Karayiorgou M (2004) The contribution of three strong candidate schizophrenia susceptibility genes in demographically distinct populations. Genes Brain Behav 3:240–248

    Article  PubMed  CAS  Google Scholar 

  13. Law A (2003) Schizophrenia, IV: neuregulin-1 in the human brain. Am J Psychiatry 160:1392

    Article  PubMed  Google Scholar 

  14. Rieff HI, Raetzman LT, Sapp DW, Yeh HH, Siegel RE, Corfas G (1999) Neuregulin induces GABA(A) receptor subunit expression and neurite outgrowth in cerebellar granule cells. J Neurosci 19:10757–10766

    PubMed  CAS  Google Scholar 

  15. Liu Y, Ford B, Mann MA, Fischbach GD (2001) Neuregulins increase alpha7 nicotinic acetylcholine receptors and enhance excitatory synaptic transmission in GABAergic interneurons of the hippocampus. J Neurosci 21:5660–5669

    PubMed  CAS  Google Scholar 

  16. Stefansson H, Sarginson J, Kong A, Yates P, Steinthorsdottir V, Gudfinnsson E, Gunnarsdottir S, Walker N, Petursson H, Crombie C, Ingason A, Gulcher JR, Stefansson K, Clair DS (2003) Association of neuregulin 1 with schizophrenia confirmed in a Scottish population. Am J Hum Genet 72:83–87

    Article  PubMed  CAS  Google Scholar 

  17. Sambrook J, Fritsch EF, Maniatis T (1989) Commonly used techniques in molecular cloning. Molecular cloning: a laboratory manual, 2nd edn, vol. 1, Cold Spring Harbor Laboratory Press, NY

  18. Yang JZ, Si TM, Ruan Y, Ling YS, Han YH, Wang XL, Zhou M, Zhang HY, Kong QM, Liu C, Zhang DR, Yu YQ, Liu SZ, Ju GZ, Shu L, Ma DL, Zhang D (2003) Association study of neuregulin 1 gene with schizophrenia. Molecular Psychiatry 8:706–709

    Article  PubMed  CAS  Google Scholar 

  19. Stefansson H, Sigurdsson E, Steinthorsdottir V, Bjornsdottir S, Sigmundsson T, Ghosh S, Brynjolfsson J, Gunnarsdottir S, Ivarsson O, Chou TT, Hjaltason O, Birgisdottir B, Jonsson H, Gudnadottir VG, Gudmundsdottir E, Bjornsson A, Ingvarsson B, Ingason A, Sigfusson S, Hardardottir H, Harvey RP, Lai D, Zhou M, Brunner D, Mutel V, Gonzalo A, Lemke G, Sainz J, Johannesson G, Andresson T, Gudbjartsson D, Manolescu A, Frigge ML, Gurney ME, Kong A, Gulcher JR, Petursson H, Stefansson K (2002) Neuregulin 1 and susceptibility to schizophrenia. Am J Hum Genet 71:877–892

    Article  PubMed  Google Scholar 

  20. Boin F, Zanardini R, Pioli R, Altamura CA, Maes M, Gennarelli M (2001) Association between −G308A tumor necrosis factor alpha gene polymorphism and schizophrenia. Molecular Psychiatry 6:79–82

    Article  PubMed  CAS  Google Scholar 

  21. Pae C, Jeong-Ho C, Won-Myong B, Hoon H, Tae-Youn J, Kwang-Soo K, Yong-Sil K, Alessandro S (2003) Tumor necrosis factor-α gene polymorphism at position −308 and schizophrenia in the Korean population. Psychiatry Clin Neurosci 57:399–403

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Institute of Biochemistry and Biotechnology, University of the Punjab, Lahore, 54590, Pakistan

    Mamoona Naz, Maria Riaz & Mahjabeen Saleem

Authors
  1. Mamoona Naz
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Maria Riaz
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Mahjabeen Saleem
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Mahjabeen Saleem.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Naz, M., Riaz, M. & Saleem, M. Potential role of Neuregulin 1 and TNF-alpha (−308) polymorphism in schizophrenia patients visiting hospitals in Lahore, Pakistan. Mol Biol Rep 38, 4709–4714 (2011). https://doi.org/10.1007/s11033-010-0606-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11033-010-0606-0

Keywords

Search

Navigation